ATE194917T1 - Flüssige beta-interferon formulierungen - Google Patents

Flüssige beta-interferon formulierungen

Info

Publication number
ATE194917T1
ATE194917T1 AT95921749T AT95921749T ATE194917T1 AT E194917 T1 ATE194917 T1 AT E194917T1 AT 95921749 T AT95921749 T AT 95921749T AT 95921749 T AT95921749 T AT 95921749T AT E194917 T1 ATE194917 T1 AT E194917T1
Authority
AT
Austria
Prior art keywords
formulations
beta interferon
interferon formulations
liquid beta
interferon
Prior art date
Application number
AT95921749T
Other languages
English (en)
Inventor
Fabrizio Samaritani
Patrizia Natale
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE194917T1 publication Critical patent/ATE194917T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95921749T 1994-05-16 1995-05-15 Flüssige beta-interferon formulierungen ATE194917T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM940300A IT1272252B (it) 1994-05-16 1994-05-16 Formulazioni liquide di interferone beta
PCT/EP1995/001825 WO1995031213A1 (en) 1994-05-16 1995-05-15 IFN-β LIQUID FORMULATIONS

Publications (1)

Publication Number Publication Date
ATE194917T1 true ATE194917T1 (de) 2000-08-15

Family

ID=11402534

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95921749T ATE194917T1 (de) 1994-05-16 1995-05-15 Flüssige beta-interferon formulierungen

Country Status (13)

Country Link
US (2) US6852314B1 (de)
EP (1) EP0759775B1 (de)
JP (1) JP3701675B2 (de)
AT (1) ATE194917T1 (de)
AU (1) AU704827B2 (de)
CA (1) CA2190465A1 (de)
DE (1) DE69518152T2 (de)
DK (1) DK0759775T3 (de)
ES (1) ES2148526T3 (de)
GR (1) GR3034309T3 (de)
IT (1) IT1272252B (de)
PT (1) PT759775E (de)
WO (1) WO1995031213A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952300A (en) * 1996-04-19 1999-09-14 Merck & Co., Inc. Antifungal compositions
TR199901968T2 (xx) * 1996-12-24 1999-12-21 Biogen, Inc. Sabit s�v� interferon form�lleri.
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
EP1426058A3 (de) 1997-09-23 2004-07-28 Dr. Rentschler Biotechnologie GmbH Flüssige Interferon-Beta Formulierungen
KR19990075253A (ko) * 1998-03-18 1999-10-15 성재갑 약학적으로 안정한 인터페론 제
ATE367828T1 (de) * 1998-04-03 2007-08-15 Novartis Vaccines & Diagnostic Igf-enthaltende injizierbare formulierungen enthaltend succinate als puffermittel
EP1343518B1 (de) 2000-11-07 2009-07-22 Novartis Vaccines and Diagnostics, Inc. Stabilisierte interferonzusammensetzungen
US6887462B2 (en) * 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
AR034749A1 (es) * 2001-07-09 2004-03-17 Schering Ag Formulaciones de interferon beta humano
TWI272948B (en) 2003-05-01 2007-02-11 Ares Trading Sa HSA-free stabilized interferon liquid formulations
ZA200609412B (en) 2004-05-17 2008-07-30 Ares Trading Sa Hydrogel interferon formulations
JP4988562B2 (ja) * 2004-06-01 2012-08-01 アレス トレーディング ソシエテ アノニム 安定化したインターフェロン液体製剤
US7913435B1 (en) * 2005-09-28 2011-03-29 Hummel Iii John F Vehicle display bracket system
JP5563475B2 (ja) * 2007-12-20 2014-07-30 メルク セローノ ソシエテ アノニム Ｐｅｇインターフェロン−ベータ製剤
US20120269770A1 (en) * 2010-11-22 2012-10-25 Mark Brader Stable Preserved Compositions of Interferon-Beta
WO2017170626A1 (ja) * 2016-03-30 2017-10-05 千寿製薬株式会社 水性液剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821691A (ja) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd α−及びβ−インタ−フェロンの精製方法
EP0080879B1 (de) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Stabilisiertes Interferon enthaltende pharmazeutische Zusammensetzung
AU1234383A (en) * 1982-03-17 1983-09-22 Inter-Yeda Ltd. Interferon stabilised with polyvinyl-pyrrolidone
US5643566A (en) * 1982-09-23 1997-07-01 Cetus Corporation Formulation processes for lipophilic proteins
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
CA1294215C (en) 1986-10-27 1992-01-14 Ze'ev Shaked Pharmaceutical compositions of recombinant beta-interferon and formulation processes
IL88233A (en) 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
US5004605A (en) * 1987-12-10 1991-04-02 Cetus Corporation Low pH pharmaceutical compositions of recombinant β-interferon

Also Published As

Publication number Publication date
PT759775E (pt) 2000-11-30
AU2670495A (en) 1995-12-05
DE69518152D1 (de) 2000-08-31
US7407651B2 (en) 2008-08-05
ITRM940300A0 (it) 1994-05-16
JP3701675B2 (ja) 2005-10-05
ES2148526T3 (es) 2000-10-16
AU704827B2 (en) 1999-05-06
US20040265270A1 (en) 2004-12-30
JPH10500125A (ja) 1998-01-06
DE69518152T2 (de) 2000-12-14
EP0759775B1 (de) 2000-07-26
IT1272252B (it) 1997-06-16
CA2190465A1 (en) 1995-11-23
DK0759775T3 (da) 2000-11-13
GR3034309T3 (en) 2000-12-29
WO1995031213A1 (en) 1995-11-23
ITRM940300A1 (it) 1995-11-16
EP0759775A1 (de) 1997-03-05
US6852314B1 (en) 2005-02-08

Similar Documents

Publication Publication Date Title
ATE194917T1 (de) Flüssige beta-interferon formulierungen
EE200100223A (et) Interferoon-beetaga sulandatud valgud ja nende kasutamine
NO941186D0 (no) Hormonanaloger med multiple CTP-forlengelser
IT8619338A0 (it) Peptide sintetico ad attivita'interleukina 1 umana.
DE3781263D1 (de) Peptid-derivate und deren verwendung in der therapie.
ES2136596T3 (es) Hil-6 modificada.
EP0349594A4 (en) Recombinant baculovirus occlusion bodies in vaccines and biological insecticides
DK151985A (da) Humant fysiologisk aktivt polypeptid
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
IT1175508B (it) Un plasmide ricombinante, un microorganismo trasformante un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la proteina cosi' prodotta
FR2691465B1 (fr) Complexes comprenant au moins un peptide derive de l'alpha msh, peptide, microsphere, medicament et composition galenique les comprenant.
ES2177625T3 (es) Citoquina cc-1 humana circulante.
IL102346A0 (en) Cysteine depleted il-6 muteins
TR199901190T2 (xx) Interferon-(alfa) N�kleik asitlerinin verilmesi ve sentezlenmesi i�in y�ntemler ve bile�imler.
ATE109206T1 (de) O-glycosylierter igf-1.
FI893587L (fi) Menetelmä ei-glykosyloidun rekombinantti-humaani-IL2:n valmistamiseksi sen pelkistyneessä muodossa
IL106591A0 (en) An interferon alpha/beta binding protein,its preparation and pharmaceutical compositions containing it
FI895456A0 (fi) Rekombinant interleukin 2-hybridproteiner.
AU7637796A (en) Expression of active interferon beta 1 using recombinant rna replicons
IT8821667A0 (it) Procedimento per la preparazione di interleuchina 1 beta umana ricombinante in forma omogenea.
IT1230755B (it) Sistema di articolazione per mobili e suo procedimento di montaggio.
IT9003692A0 (it) Dispositivo per l' assemblaggio di pannelli di mobili in genere.
Hee Pancreatic secretions in the growing pig
NO910331D0 (no) Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.
NO893572L (no) Lunge-overflateaktivt protein og beslektet polypeptid.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification